Professor Stephen Riordan

Gastroenterology and the Liver

MBBS (Hons), MD (UNSW), FRACP, FRCP (London)

Scientific Publications

113. Liver transplantation for hepatocellular carcinoma. Best Practice and Research in Clinical Gastroenterology 2005 19: 147-160.
114. Fulminant liver failure. Current Treatment Options in Gastroenterology 2005; 8: 503-518.
115. Acalculous cholecystitis, multifocal gastrointestinal infarction and pancreatitis due to Varicella-Zoster virus. Internal Medicine Journal 2005; 35: 69-70.
116. Natural history of primary biliary cirrhosis. Quarterly Journal of Medicine 2005; 98: 331-336.
117. Dietary fiber reduces ammonia levels in patients with cirrhosis. 2005; 41: 219.
118. FDG PET for discrimination between tumour extension and blood thrombus as a cause of portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy. Clinical Nuclear Medicine 2005; 30: 408-410.
119. Culture-proven small intestinal bacterial overgrowth as a cause of irritable bowel syndrome: response to lactulose but not broad-spectrum antibiotics. Journal of Gastroenterology 2005; 40: 767-770.
120. Transplantation for Fulminant Hepatic Failure. In: Busuttil RW, Klintmalm GB (Eds). Transplantation of the Liver, 2nd Edition, Elsevier Saunders, Philadelphia, 2005: 161-175.
121. Up-regulation of Toll-like receptor expression in chronic hepatitis C: correlation with circulating pro-inflammatory cytokine levels and hepatic necro-inflammatory activity. Hepatology 2005; 42(Suppl): 547A.
122. Prevalence of Human Mouse Mammary Tumour Virus-Like Virus (HMLV) in Australian Breast and Liver Tissue. Proceedings of Tow Research Awards, Sydney, October 2005
123. Modulation of intestinal flora for the treatment of hepatic encephalopathy in cirrhosis. In: Haussinger D, Kircheis D, Schleiss F (Eds). Hepatic Encephalopathy and Nitrogen Metabolism. Springer, Dordrecht, The Netherlands, 2006; 539-550.
124. Gut flora, bacterial translocation and chronic liver disease. World Journal of Gastroenterology 2006; 12: 1493-1502.
125. Toll-like receptor expression in chronic hepatitis C: correlation with circulating pro-inflammatory cytokine levels and liver injury. Inflammation Research 2006; 55: 279-285.
126. Reduced expression of Toll-like receptor 2 on peripheral monocytes in chronic hepatitis B. Clinical and Vaccine Immunology 2006; 13: 972-974.
127. Bacterial overgrowth as a cause of irritable bowel syndrome. Current Opinion in Gastroenterology 2006; 22: 669-673.
128. The intestinal flora and bacterial infection in cirrhosis. Journal of Hepatology 2006; 45: 744-757.
129. Regulation of Toll-like receptor 2 expression in chronic hepatitis B by the precore protein. Hepatology 2007; 45: 102-110.